2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
12
Leukemia
12
Breast Neoplasms
11
Leukemia, Myeloid, Acute
9
Congenital Abnormalities
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Myeloproliferative Disorders
7
Multiple Myeloma
7
Lymphoma, Mantle-Cell
7
Lymphoma, Follicular
6
Lymphoma, B-Cell, Marginal Zone
6
Waldenstrom Macroglobulinemia
5
Myelodysplastic Syndromes
5
Lymphoma, Non-Hodgkin
5
Lymphoma, Large B-Cell, Diffuse
5
Leukemia, Myelomonocytic, Chronic
5
Leukemia, Myeloid, Chronic-Phase
5
Colorectal Neoplasms
5
Colonic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Burkitt Lymphoma
5
Squamous Cell Carcinoma of Head and Neck
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma
4
Lung Neoplasms
4
Leukemia, Myeloid, Accelerated Phase
4
Head and Neck Neoplasms
4
Central Nervous System Neoplasms
4
Blast Crisis
4
Sezary Syndrome
3
Interventions
Fluorouracil
67
Radiotherapy
53
Cisplatin
52
Oxaliplatin
47
Leucovorin
37
Paclitaxel
36
Irinotecan
27
Docetaxel
23
Capecitabine
20
Nivolumab
17
Carboplatin
16
pembrolizumab
15
Radiation
15
Neoadjuvant Therapy
15
Surgical Procedures, Operative
12
Cetuximab
12
durvalumab
9
Drug Therapy
9
Biopsy
9
Taxes
8
Folfox protocol
8
Chemotherapy, Adjuvant
8
Trastuzumab
7
Magnetic Resonance Spectroscopy
7
Gefitinib
7
Endoscopy
7
tremelimumab
6
Specimen Handling
6
Endoscopy, Digestive System
6
Ramucirumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenocarcinoma Of Esophagus
×
In Situ Hybridization, Fluorescence
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled